Insulin-dependent diabetes mellitus
|
n = 174
|
n = 182
| |
Insulins and analogues
|
147 (84)
|
155 (85)
|
1.01 (0.80–1.26)
|
Fast-acting
|
103 (59)
|
80 (44)
|
0.74 (0.55–0.99)
|
Intermediate-acting
|
71 (41)
|
57 (31)
|
0.77 (0.56–1.09)
|
Intermediate/long-acting comb. fast-acting
|
52 (30)
|
96 (53)
|
1.77 (1.26–2.47)
|
Long-acting
|
65 (37)
|
62 (34)
|
0.91 (0.64–1.29)
|
Blood glucose lowering drugs excl. Insulins
|
96 (55)
|
126 (69)
|
1.26 (0.96–1.64)
|
Biguanides
|
91 (52)
|
112 (62)
|
1.18 (0.89–1.55)
|
Sulfonylureas
|
27 (16)
|
55 (30)
|
1.95 (1.23–3.09)
|
Combinations
|
4 (2)
|
2 (1)
|
NC
|
α glucosidase inhibitors
|
3 (2)
|
4 (2)
|
NC
|
Thiazolidinediones
|
5 (3)
|
3 (2)
|
NC
|
Dipeptidyl peptidase-4 inhibitors
|
8 (5)
|
2 (1)
|
NC
|
Repaglinide or nateglinide
|
10 (6)
|
7 (4)
|
0.67 (0.26–1.76)
|
Exenatide or liraglutide
|
1 (1)
|
3 (2)
|
NC
|
Non-insulin-dependent diabetes
|
n = 546
|
n = 664
| |
Insulins and analogues
|
252 (46)
|
338 (51)
|
1.10 (0.94–1.30)
|
Fast-acting
|
125 (23)
|
136 (20)
|
0.90 (0.70–1.14)
|
Intermediate-acting
|
131 (24)
|
129 (19)
|
0.81 (0.64–1.03)
|
Intermediate/long-acting comb. fast-acting
|
114 (21)
|
212 (32)
|
1.53 (1.22–1.92)
|
Long-acting
|
84 (15)
|
100 (15)
|
0.98 (0.73–1.31)
|
Blood glucose lowering drugs excl. Insulins
|
423 (77)
|
528 (80)
|
1.03 (0.90–1.17)
|
Biguanides
|
398 (73)
|
473 (71)
|
0.98 (0.86–1.12)
|
Sulfonylureas
|
150 (27)
|
230 (35)
|
1.26 (1.03–1.55)
|
Combinations
|
20 (4)
|
11 (2)
|
0.45 (0.22–0.94)
|
α glucosidase inhibitors
|
6 (1)
|
8 (1)
|
1.10 (0.38–3.16)
|
Thiazolidinediones
|
23 (4)
|
21 (3)
|
0.75 (0.42–1.36)
|
Dipeptidyl peptidase-4 inhibitors
|
42 (8)
|
2 (3)
|
0.43 (0.26–0.72)
|
Repaglinide or nateglinide
|
34 (6)
|
36 (5)
|
0.87 (0.55–1.39)
|
Exenatide or liraglutide
|
15 (3)
|
7 (1)
|
0.38 (0.16–0.94)
|
Hypertension
|
n = 1487
|
n = 814
| |
Diuretics
|
641 (43)
|
482 (59)
|
1.37 (1.22–1.55)
|
Beta blocking agents
|
953 (64)
|
497 (61)
|
0.95 (0.86–1.06)
|
Calcium channel blockers
|
792 (53)
|
362 (44)
|
0.84 (0.74–0.95)
|
Agents acting on the renin-angiotensin system
|
1184 (80)
|
543 (67)
|
0.84 (0.75–0.93)
|
ACE inhibitors
|
863 (58)
|
463 (57)
|
0.98 (0.88–1.10)
|
Angiotensin II antagonists
|
614 (41)
|
145 (18)
|
0.43 (0.36–0.52)
|